Free tool
FAERS Monitor: Fentanyl Citrate
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 215870 or its brand name (Fentanyl Citrate, Fentanyl Citrate). Reports on generic versions are filed under their own applications.
Reports
17,840
Serious
15,772
88% of reports
Hospitalization
3,551
Death reported
6,175
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dependence3,935
- overdose2,456
- death2,065
- drug abuse1,737
- toxicity to various agents1,385
- ill-defined disorder1,288
- cardiac arrest918
- respiratory arrest737
- drug ineffective715
- drug hypersensitivity628
- nausea607
- pain574
- wrong technique in drug usage process488
- off label use458
- accidental overdose457
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 72 |
| 2005 | 115 |
| 2006 | 235 |
| 2007 | 154 |
| 2008 | 261 |
| 2009 | 272 |
| 2010 | 1,148 |
| 2011 | 563 |
| 2012 | 696 |
| 2013 | 404 |
| 2014 | 429 |
| 2015 | 510 |
| 2016 | 595 |
| 2017 | 1,230 |
| 2018 | 1,319 |
| 2019 | 1,207 |
| 2020 | 1,031 |
| 2021 | 760 |
| 2022 | 834 |
| 2023 | 4,700 |
| 2024 | 599 |
| 2025 | 432 |
| 2026 | 272 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,036,319 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| dependenceSignal | 3,935 | 91.1 | 88.5 | 326,235 |
| respiratory arrestSignal | 737 | 32.4 | 30.1 | 21,809 |
| ill-defined disorderSignal | 1,288 | 25.5 | 24.2 | 29,757 |
| drug abuseSignal | 1,737 | 25.1 | 24.0 | 39,496 |
| wrong technique in drug usage processSignal | 488 | 16.0 | 14.7 | 6,784 |
| accidental overdoseSignal | 457 | 14.9 | 13.6 | 5,850 |
| overdoseSignal | 2,456 | 13.6 | 13.1 | 28,543 |
| cardiac arrestSignal | 918 | 13.2 | 12.4 | 10,305 |
| toxicity to various agentsSignal | 1,385 | 9.8 | 9.3 | 10,871 |
| drug hypersensitivitySignal | 628 | 3.8 | 3.6 | 1,321 |
| deathSignal | 2,065 | 2.8 | 2.7 | 2,541 |
| pain | 574 | 1.1 | 1.0 | 5 |
| nausea | 607 | 0.9 | 0.8 | 6 |
| drug ineffective | 715 | 0.6 | 0.6 | 155 |
| off label use | 458 | 0.6 | 0.6 | 114 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.